AIM bulletins from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Faron strengthens bexmarilimab potential with fresh trial data
Mon 20 October 2025 10:04
(Sharecast News) - Faron Pharmaceuticals said on Monday that updated results from its phase one and two 'BEXMAB' study showed further improvement in the clinical performance of bexmarilimab, strengthening the drug's profile as a treatment for newly diagno
Avacta raises £16m, releases solid clinical trial data
Mon 20 October 2025 09:01
(Sharecast News) - Avacta Group announced on Monday that it has raised £16m through an oversubscribed equity placing to accelerate development of its oncology pipeline, as new clinical data presented at the European Society for Medical Oncology (ESMO) de
Winvia to float on London's AIM market
Mon 20 October 2025 08:26
(Sharecast News) - Prize draw operator Winvia has confirmed its intention for an initial public offering on London's junior AIM market, seeking to raise roughly £40m from the sale of new shares at an expected valuation of approximately £200m.
Chill Brands pivots to multi-brand distribution model, eyes growth in nicotine alternatives
Mon 20 October 2025 07:43
(Sharecast News) - Fast-moving consumer packaged goods company Chill Brands said on Monday that it has transitioned into a diversified distribution and services group, moving away from its previous own-brand model to focus on broader partnerships across t